Valisure relies on ultraWAVE to ensure drugs are safe for customers



Founded in 2015, Valisure is the first and only pharmacy to independently batch-test the medications they receive to confirm the drugs are suitable for their customers before they dispense them. With an estimated 80 percent of ingredients in U.S. medications now being manufactured overseas and approximately four drug recalls in the U.S. every day, medication quality is constantly called into question. Seeing the need to “chemically validate” the drugs that it receives prior to dispensing them, Valisure tests for correct dosage, major inactive ingredients, proper dissolution, and the presence of carcinogens and/or trace metals. Currently, Valisure estimates that it rejects over 10% of on-market medication batches based on these testing standards.
Valisure does not manufacture any medications. They purchase their medications from the same American distributors used by other pharmacies.


To meet their metals testing requirement, Valisure’s laboratory needs sample prep solutions that enable them to quickly dispense rigorously-tested and verified medications to their customers.
Valisure performs rigorous independent testing on its medications prior to dispensing them to consumers. In early 2019, Valisure’s corporate team made the decision to add USP <232>/<233> testing to its lengthy list of testing standards, which makes it necessary for them to run trace metals testing on a broad range of medications. The vast differences in reactivity of the samples they needed to prepare made it apparent that they would face a sample bottleneck if they employed a rotor-based microwave digestion solution for their testing, since these systems typically prepare only one type of sample per run. The corporate team also wanted a solution that would be quick to adopt, so they could start testing medications as soon as possible.
The ultraWAVE has been amazing and has allowed us to keep up with our business demands. Without the ultraWAVE’s ability to run mix-batch samples, we likely would have been forced to choose between testing only pharmaceutical or supplement samples. Instead, today we’re able to run everything, from patches to creams to topicals to tablets, everything we need in just a few runs per day
- Kaury Kucera, PhD, Chief Scientific Officer
  • Valisure


Milestone’s ultraWAVE allows mixed sample types to be digested in the same run, while ensuring all samples reach the same high temperature and pressure required for complete digestion. This capability dramatically speeds up processing and eliminates under-digested samples. In addition, the ultraWAVE’s unique design prevents venting, which provides reliable recoveries for volatile elements such as mercury and sulfur. If they were to employ a rotor-based system, Valisure quickly realized that this would result in an unacceptable bottleneck in their process due to the wide range of medications they dispense.


The ultraWAVE is based on the SRC (Single Reaction Chamber) technology, that achieves extraordinary performance capabilities combining microwave heating with a high-pressure reactor which acts simultaneously as microwave cavity and vessel.

Download the Lab Profile

Read the complete document here
The ability to process mixed-batch samples in the same run is one of the primary reasons behind Valisure’s decision to purchase an ultraWAVE.